Diffuse calcifications protect carotid plaques regardless of the amount of neoangiogenesis and related histological complications.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Source:
      Publisher: Hindawi Pub. Co Country of Publication: United States NLM ID: 101600173 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2314-6141 (Electronic) NLM ISO Abbreviation: Biomed Res Int Subsets: MEDLINE
    • Publication Information:
      Original Publication: New York, NY : Hindawi Pub. Co.
    • Subject Terms:
    • Abstract:
      Background: Neoangiogenesis is crucial in plaque progression and instability. Previous data from our group showed that Nestin-positive intraplaque neovessels correlated with histological complications. The aim of the present work is to evaluate the relationship between neoangiogenesis, plaque morphology, and clinical instability of the plaque.
      Materials and Methods: Seventy-three patients (53 males and 20 females, mean age 71 years) were consecutively enrolled. Clinical data and 14 histological variables, including intraplaque hemorrhage and calcifications, were collected. Immunohistochemistry for CD34 and Nestin was performed. RT-PCR was performed to evaluate Nestin mRNA (including 5 healthy arteries as controls).
      Results: Diffusely calcified plaques (13/73) were found predominantly in females (P = 0.017), with a significantly lower incidence of symptoms (TIA/stroke (P = 0.019) than noncalcified plaques but with the same incidence of histological complications (P = 0.156)). Accordingly, calcified and noncalcified plaques showed similar mean densities of positivity for CD34 and Nestin. Nestin density, but not CD34, correlated with the occurrence of intraplaque hemorrhage.
      Conclusions: Plaques with massive calcifications show the same incidence of histological complications but without influencing symptomatology, especially in female patients, and regardless of the amount of neoangiogenesis. These results can be applied in a future presurgical identification of patients at major risk of developing symptoms.
    • References:
      J Vasc Surg. 1999 Aug;30(2):261-8. (PMID: 10436445)
      Br J Surg. 2001 Jul;88(7):945-50. (PMID: 11442525)
      Circulation. 2005 Jul 26;112(4):572-7. (PMID: 16009800)
      BMC Bioinformatics. 2006;7:85. (PMID: 16504059)
      Circulation. 2006 May 9;113(18):2245-52. (PMID: 16684874)
      Proc Natl Acad Sci U S A. 2006 Oct 3;103(40):14678-83. (PMID: 17003118)
      Arterioscler Thromb Vasc Biol. 2004 Feb;24(2):331-6. (PMID: 14656730)
      J Am Coll Cardiol. 1998 Jan;31(1):126-33. (PMID: 9426030)
      Ann Intern Med. 1998 Dec 15;129(12):1050-60. (PMID: 9867761)
      J Am Coll Cardiol. 2009 Apr 28;53(17):1517-27. (PMID: 19389562)
      Acta Chir Belg. 2010 Mar-Apr;110(2):159-64. (PMID: 20514826)
      Menopause. 2010 Sep-Oct;17(5):902-7. (PMID: 20512078)
      Eur J Vasc Endovasc Surg. 2011 Feb;41(2):238-48. (PMID: 21145266)
      Histol Histopathol. 2012 Sep;27(9):1195-202. (PMID: 22806906)
      Histol Histopathol. 2014 Dec;29(12):1565-73. (PMID: 24861148)
      N Engl J Med. 2007 Jun 21;356(25):2591-602. (PMID: 17582069)
      J Vasc Surg. 2008 Aug;48(2):480-6. (PMID: 18644494)
      Eur J Vasc Endovasc Surg. 2009 Apr;37(4 Suppl):1-19. (PMID: 19286127)
      Arterioscler Thromb Vasc Biol. 2000 May;20(5):1177-8. (PMID: 10807728)
      JAMA. 2000 Jun 7;283(21):2810-5. (PMID: 10838649)
      Circulation. 2001 Feb 27;103(8):1051-6. (PMID: 11222465)
      Arch Intern Med. 2005 Mar 14;165(5):510-5. (PMID: 15767525)
    • Accession Number:
      0 (Antigens, CD34)
      0 (NES protein, human)
      0 (Nestin)
    • Publication Date:
      Date Created: 20150418 Date Completed: 20160108 Latest Revision: 20181113
    • Publication Date:
      20240104
    • Accession Number:
      PMC4389976
    • Accession Number:
      10.1155/2015/795672
    • Accession Number:
      25883974